113 related articles for article (PubMed ID: 26489674)
21. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
Christensen LL; Tobiasen H; Holm A; Schepeler T; Ostenfeld MS; Thorsen K; Rasmussen MH; Birkenkamp-Demtroeder K; Sieber OM; Gibbs P; Lubinski J; Lamy P; ; Laurberg S; Oster B; Hansen KQ; Hagemann-Madsen R; Byskov K; Ørntoft TF; Andersen CL
Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
[TBL] [Abstract][Full Text] [Related]
22. FOXP1 and BCL2 show similar immunoenzymatic pattern in bone marrow trephines of chronic lymphocytic leukemia patients.
Korać P; Vintar MG; Ajduković R; Kardum Paro MM; Jaksić B; Dominis M
Appl Immunohistochem Mol Morphol; 2009 Dec; 17(6):500-4. PubMed ID: 19417623
[TBL] [Abstract][Full Text] [Related]
23. FOXP1 status in splenic marginal zone lymphoma: a fluorescence in situ hybridization and immunohistochemistry approach.
Baró C; Espinet B; Salido M; Colomo L; Luño E; Florensa L; Ferrer A; Salar A; Campo E; Serrano S; Solé F
Histol Histopathol; 2009 Nov; 24(11):1399-404. PubMed ID: 19760589
[TBL] [Abstract][Full Text] [Related]
24. FOXP1 expression and its clinicopathologic significance in nodal and extranodal diffuse large B-cell lymphoma.
Yu B; Zhou X; Li B; Xiao X; Yan S; Shi D
Ann Hematol; 2011 Jun; 90(6):701-8. PubMed ID: 21120478
[TBL] [Abstract][Full Text] [Related]
25. FOXP1 has a low expression in human gliomas and its overexpression inhibits proliferation, invasion and migration of human glioma U251 cells.
Xue L; Yue S; Zhang J
Mol Med Rep; 2014 Jul; 10(1):467-72. PubMed ID: 24789678
[TBL] [Abstract][Full Text] [Related]
26. N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer.
Yan X; Yan L; Liu S; Shan Z; Tian Y; Jin Z
Mol Med Rep; 2015 Aug; 12(2):2999-3006. PubMed ID: 25936636
[TBL] [Abstract][Full Text] [Related]
27. Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma.
Banham AH; Connors JM; Brown PJ; Cordell JL; Ott G; Sreenivasan G; Farinha P; Horsman DE; Gascoyne RD
Clin Cancer Res; 2005 Feb; 11(3):1065-72. PubMed ID: 15709173
[TBL] [Abstract][Full Text] [Related]
28. Preferential expression of truncated isoforms of FOXP1 in primary central nervous system lymphoma.
Courts C; Brunn A; Montesinos-Rongen M; Siemer D; Hans V; Paulus W; Wiestler OD; Küppers R; Siebert R; Deckert M
J Neuropathol Exp Neurol; 2009 Sep; 68(9):972-6. PubMed ID: 19680146
[TBL] [Abstract][Full Text] [Related]
29. PRMT5 and FOXP1 expression profile in invasive breast cancer patients undergoing neoadjuvant chemotherapy.
Su H; Liu Y; Zhang C; Yu T; Niu Y
Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):142-145. PubMed ID: 32415941
[TBL] [Abstract][Full Text] [Related]
30. Forkhead box P1 overexpression and its clinicopathologic significance in peripheral T-cell lymphoma, not otherwise specified.
Yamada S; Sato F; Xia H; Takino H; Kominato S; Ri M; Ishida T; Iida S; Inagaki H; Yamada K
Hum Pathol; 2012 Aug; 43(8):1322-7. PubMed ID: 22401769
[TBL] [Abstract][Full Text] [Related]
31. Knockdown of FOXP1 promotes the development of lung adenocarcinoma.
Sheng H; Li X; Xu Y
Cancer Biol Ther; 2019; 20(4):537-545. PubMed ID: 30409062
[TBL] [Abstract][Full Text] [Related]
32. Regulator of Chromosome Condensation 2 Identifies High-Risk Patients within Both Major Phenotypes of Colorectal Cancer.
Bruun J; Kolberg M; Ahlquist TC; Røyrvik EC; Nome T; Leithe E; Lind GE; Merok MA; Rognum TO; Bjørkøy G; Johansen T; Lindblom A; Sun XF; Svindland A; Liestøl K; Nesbakken A; Skotheim RI; Lothe RA
Clin Cancer Res; 2015 Aug; 21(16):3759-70. PubMed ID: 25910952
[TBL] [Abstract][Full Text] [Related]
33. DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.
Su CY; Lin TC; Lin YF; Chen MH; Lee CH; Wang HY; Lee YC; Liu YP; Chen CL; Hsiao M
Oncotarget; 2015 Jul; 6(21):18602-12. PubMed ID: 26087195
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.
Umetani N; Takeuchi H; Fujimoto A; Shinozaki M; Bilchik AJ; Hoon DS
Clin Cancer Res; 2004 Nov; 10(22):7475-83. PubMed ID: 15569977
[TBL] [Abstract][Full Text] [Related]
35. Detailed expression pattern of Foxp1 and its possible roles in neurons of the spinal cord during embryogenesis.
Morikawa Y; Komori T; Hisaoka T; Senba E
Dev Neurosci; 2009; 31(6):511-22. PubMed ID: 19797899
[TBL] [Abstract][Full Text] [Related]
36. Expression of the Forkhead transcription factor FOXP1 is associated with tumor grade and Ki67 expression in clear cell renal cell carcinoma.
Toma MI; Weber T; Meinhardt M; Zastrow S; Grimm MO; Füssel S; Wirth MP; Baretton GB
Cancer Invest; 2011 Feb; 29(2):123-9. PubMed ID: 21210727
[TBL] [Abstract][Full Text] [Related]
37. Expression of Cancer Testis Antigens in Colorectal Cancer: New Prognostic and Therapeutic Implications.
Tarnowski M; Czerewaty M; Deskur A; Safranow K; Marlicz W; Urasińska E; Ratajczak MZ; Starzyńska T
Dis Markers; 2016; 2016():1987505. PubMed ID: 27635108
[TBL] [Abstract][Full Text] [Related]
38. Effects of lentiviral-mediated Foxp1 and Foxq1 RNAi on the hepatocarcinoma cell.
Qin J; Xu Y; Li X; Wu Y; Zhou J; Wang G; Chen L
Exp Mol Pathol; 2014 Feb; 96(1):1-8. PubMed ID: 24211718
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of decreased FOXP1 protein expression in various tumors: a systematic review and meta-analysis.
Xiao J; He B; Zou Y; Chen X; Lu X; Xie M; Li W; He S; You S; Chen Q
Sci Rep; 2016 Jul; 6():30437. PubMed ID: 27457567
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J
Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
